(Hypertension. 1999;34:430-434.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
From Yokohama City University, Internal Medicine II, Yokohama City, Japan.
Correspondence to Tomoaki Ishigami, MD, PhD, Yokohama City University, Internal Medicine II, 3-9, Fukuura, Kanazawa-Ku, Yokohama City, Japan. E-mail utomo661{at}med.yokohama-cu.ac.jp
AbstractMolecular variants of the angiotensinogen gene, a key component of the renin-angiotensin system, are considered genetic risk factors for primary hypertension. A relation between the angiotensinogen gene locus and hypertension has been found in whites, Japanese, and African Caribbeans but not in Chinese. The lack of a consistent association between M235T polymorphism at exon 2 and hypertension has suggested that another site in linkage disequilibrium with M235T is the causal mutation. We studied the relations among plasma angiotensinogen concentrations, blood pressure, related clinical variables, and mutations of the 5' upstream core promoter region of the human angiotensinogen gene in 274 subjects recruited from our outpatient clinic. We confirmed that plasma angiotensinogen concentration was significantly correlated with A-20C mutation and percent body fat and found that systolic and diastolic blood pressures were significantly correlated with G-6A and T+68C mutations. These results suggest that mutations near the transcription start site may be associated with increased blood pressure.
Key Words: angiotensinogen blood pressure polymorphism transcription, genetic hypertension, essential
This article has been cited by other articles:
![]() |
J.-M. Lalouel and A. Rohrwasser Genetic Susceptibility to Essential Hypertension: Insight From Angiotensinogen Hypertension, March 1, 2007; 49(3): 597 - 603. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Engeli, J. Bohnke, K. Gorzelniak, J. Janke, P. Schling, M. Bader, F. C. Luft, and A. M. Sharma Weight Loss and the Renin-Angiotensin-Aldosterone System Hypertension, March 1, 2005; 45(3): 356 - 362. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Levesque, J.-M. Moutquin, C. Lindsay, M.-C. Roy, and F. Rousseau Implication of an AGT Haplotype in a Multigene Association Study With Pregnancy Hypertension Hypertension, January 1, 2004; 43(1): 71 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Sethi, B. G. Nordestgaard, M.-L. M. Gronholdt, R. Steffensen, G. Jensen, and A. Tybjaerg-Hansen Angiotensinogen Single Nucleotide Polymorphisms, Elevated Blood Pressure, and Risk of Cardiovascular Disease Hypertension, June 1, 2003; 41(6): 1202 - 1211. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. LALOUEL, A. ROHRWASSER, D. TERREROS, T. MORGAN, and K. WARD Angiotensinogen in Essential Hypertension: From Genetics to Nephrology J. Am. Soc. Nephrol., March 1, 2001; 12(3): 606 - 615. [Abstract] [Full Text] |
||||
![]() |
A. M Sharma and S. Engeli The renin-angiotensin system in obesity hypertension Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S114 - S119. [PDF] |
||||
![]() |
M. Azizi, M.-C. Hallouin, X. Jeunemaitre, T. T. Guyene, and J. Ménard Influence of the M235T Polymorphism of Human Angiotensinogen (AGT) on Plasma AGT and Renin Concentrations after Ethinylestradiol Administration J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4331 - 4337. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |